drugset / Trial / NCT01142947

Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)

NCT01142947

Completed 362 enrolled Henry Ford Health System
NaSingle-groupOpen-labelBasic science

Summary

Inhaled corticosteroids (ICS) are considered first-line treatment for persistent asthma, yet little is known about the genetic factors that influence response to this therapy. This study seeks to quantify response to ICS therapy in African American and white patients, as well as look for genetic markers that predict treatment response.

Timeline

Start
2007-10
Primary completion
2017-02
Completion
2019-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject beclomethasone dipropionate Other / unclassified 160 ug Inhaled

Indications